Analyst Ratings for Coherus Biosciences (CHRS)
CHRS Rating Summary
CHRS Price Target Summary
- Highest: $21.00 (Mizuho Securities)
- Lowest: $9.00 (JPMorgan)
- Average: $13.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$13.67 (+58%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
Avg. $ Target:
$13.67 (+58%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/14/2022 | UBS » Updated 9/16/2022 |
Ashwani Verma | New Coverage | Neutral (N/A) |
11.00 (7.00) |
6.72 (8.65) |
28.72% | Details |
| 3/7/2022 | JPMorgan » Updated 12/16/2022 |
Chris Schott | Downgrade | Neutral (Overweight) |
9.00 (11.00) |
11.56 (8.65) |
-25.17% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
